Tsang KY - Search Results

1

Evaluation of the Anti-Tumor Activity of the Humanized Monoclonal Antibody NEO-201 in Preclinical Models of Ovarian Cancer.

Zeligs KP, Morelli MP, David JM, Neuman M, Hernandez L, Hewitt S, Ozaki M, Osei-Tutu A, Anderson D, Andresson T, Das S, Lack J, Abdelmaksoud A, Fantini M, Arlen PM, Tsang KY, Annunziata CM. Zeligs KP, et al. Among authors: tsang ky. Front Oncol. 2020 Jun 19;10:805. doi: 10.3389/fonc.2020.00805. eCollection 2020. Front Oncol. 2020. PMID: 32637350 Free PMC article.

2

Development and Characterization of an Anti-Cancer Monoclonal Antibody for Treatment of Human Carcinomas.

Tsang KY, Fantini M, Mavroukakis SA, Zaki A, Annunziata CM, Arlen PM. Tsang KY, et al. Cancers (Basel). 2022 Jun 21;14(13):3037. doi: 10.3390/cancers14133037. Cancers (Basel). 2022. PMID: 35804808 Free PMC article. Review.

3

Preclinical Characterization of a Novel Monoclonal Antibody NEO-201 for the Treatment of Human Carcinomas.

Fantini M, David JM, Saric O, Dubeykovskiy A, Cui Y, Mavroukakis SA, Bristol A, Annunziata CM, Tsang KY, Arlen PM. Fantini M, et al. Among authors: tsang ky. Front Immunol. 2018 Jan 4;8:1899. doi: 10.3389/fimmu.2017.01899. eCollection 2017. Front Immunol. 2018. PMID: 29354121 Free PMC article.

4

The Monoclonal Antibody NEO-201 Enhances Natural Killer Cell Cytotoxicity Against Tumor Cells Through Blockade of the Inhibitory CEACAM5/CEACAM1 Immune Checkpoint Pathway.

Fantini M, David JM, Annunziata CM, Morelli MP, Arlen PM, Tsang KY. Fantini M, et al. Among authors: tsang ky. Cancer Biother Radiopharm. 2020 Apr;35(3):190-198. doi: 10.1089/cbr.2019.3141. Epub 2020 Jan 13. Cancer Biother Radiopharm. 2020. PMID: 31928422 Free PMC article.

5

An IL-15 Superagonist, ALT-803, Enhances Antibody-Dependent Cell-Mediated Cytotoxicity Elicited by the Monoclonal Antibody NEO-201 Against Human Carcinoma Cells.

Fantini M, David JM, Wong HC, Annunziata CM, Arlen PM, Tsang KY. Fantini M, et al. Among authors: tsang ky. Cancer Biother Radiopharm. 2019 Apr;34(3):147-159. doi: 10.1089/cbr.2018.2628. Epub 2019 Jan 2. Cancer Biother Radiopharm. 2019. PMID: 30601063 Free PMC article.

6

Antibody-Dependent Cellular Cytotoxicity Activity of a Novel Anti-PD-L1 Antibody Avelumab (MSB0010718C) on Human Tumor Cells.

Boyerinas B, Jochems C, Fantini M, Heery CR, Gulley JL, Tsang KY, Schlom J. Boyerinas B, et al. Among authors: tsang ky. Cancer Immunol Res. 2015 Oct;3(10):1148-1157. doi: 10.1158/2326-6066.CIR-15-0059. Epub 2015 May 26. Cancer Immunol Res. 2015. PMID: 26014098 Free PMC article.

7

Ipilimumab and a poxviral vaccine targeting prostate-specific antigen in metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial.

Madan RA, Mohebtash M, Arlen PM, Vergati M, Rauckhorst M, Steinberg SM, Tsang KY, Poole DJ, Parnes HL, Wright JJ, Dahut WL, Schlom J, Gulley JL. Madan RA, et al. Among authors: tsang ky. Lancet Oncol. 2012 May;13(5):501-8. doi: 10.1016/S1470-2045(12)70006-2. Epub 2012 Feb 10. Lancet Oncol. 2012. PMID: 22326924 Free PMC article. Clinical Trial.

8

Phase II Study of Ensituximab, a Novel Chimeric Monoclonal Antibody, in Adults with Unresectable, Metastatic Colorectal Cancer.

Kim RD, Azad NS, Morse MA, Poplin E, Mahipal A, Tan B Jr, Mavroukakis SA, Fantini M, Tsang KY, Zaki A, Torrealba J, Arlen PM, Beg MS. Kim RD, et al. Among authors: tsang ky. Clin Cancer Res. 2020 Jul 15;26(14):3557-3564. doi: 10.1158/1078-0432.CCR-20-0426. Epub 2020 Apr 17. Clin Cancer Res. 2020. PMID: 32303539 Clinical Trial.

9

A novel ELISPOT assay to enhance detection of antigen-specific T cells employing antigen-presenting cells expressing vector-driven human B7-1.

Arlen PM, Gulley JL, Palena C, Marshall J, Schlom J, Tsang KY. Arlen PM, et al. Among authors: tsang ky. J Immunol Methods. 2003 Aug;279(1-2):183-92. doi: 10.1016/s0022-1759(03)00185-6. J Immunol Methods. 2003. PMID: 12969559

10

New gene expressed in prostate: a potential target for T cell-mediated prostate cancer immunotherapy.

Cereda V, Poole DJ, Palena C, Das S, Bera TK, Remondo C, Gulley JL, Arlen PM, Yokokawa J, Pastan I, Schlom J, Tsang KY. Cereda V, et al. Among authors: tsang ky. Cancer Immunol Immunother. 2010 Jan;59(1):63-71. doi: 10.1007/s00262-009-0723-6. Epub 2009 Jun 4. Cancer Immunol Immunother. 2010. PMID: 19495750 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

246 results

Search Page